Cyclacel Pharmaceuticals Inc Tangible Net Worth Ratio
Cyclacel Pharmaceuticals Inc tangible net worth ratio. Cyclacel Pharmaceuticals Inc (CYCC) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($3.63K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Cyclacel Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Cyclacel Pharmaceuticals Inc (2004–2023)
Tangible net worth ratio of Cyclacel Pharmaceuticals Inc from 2004 to 2023. This chart shows how Cyclacel Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 20 annual periods from 2004 to 2023. As of June 2025, the ratio stands at 100.0%, reflecting net assets of $3.63K with intangible assets of $0.00 USD. See working capital position of Cyclacel Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Cyclacel Pharmaceuticals Inc Tangible Net Worth Ratio by Year (2004–2023)
Cyclacel Pharmaceuticals Inc tangible net worth ratio by year from 2004 to 2023. The table below presents the year-by-year Tangible Net Worth Ratio for Cyclacel Pharmaceuticals Inc from 2004 to 2023, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Cyclacel Pharmaceuticals Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 100.0% | $607.00K | $0.00 | $8.80 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $20.43 Million | $0.00 | $28.05 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $37.69 Million | $0.00 | $43.14 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $33.26 Million | $0.00 | $36.80 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $11.70 Million | $0.00 | $15.31 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $15.27 Million | $0.00 | $19.82 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $21.77 Million | $0.00 | $26.00 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $14.27 Million | $0.00 | $19.66 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $18.84 Million | $0.00 | $24.76 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $21.69 Million | $0.00 | $29.39 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $28.02 Million | $0.00 | $35.52 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $10.02 Million | $0.00 | $19.35 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $19.50 Million | $0.00 | $26.00 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $24.92 Million | $0.00 | $31.46 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $4.64 Million | $0.00 | $14.47 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $20.64 Million | $0.00 | $30.96 Million | ▲ +7.4 pp |
| 2007 | 92.6% | $57.97 Million | $4.30 Million | $75.91 Million | ▼ -2.3 pp |
| 2006 | 94.9% | $53.92 Million | $2.75 Million | $63.28 Million | ▼ -5.1 pp |
| 2005 | 100.0% | $14.60 Million | $0.00 | $21.45 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $44.12 Million | $0.00 | $55.60 Million | — |